Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Isolates from Burn Patients

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2017 Jul 15

PMID 28706882

Citations 17

Authors

Seyed Abolfazl Hosseininassab Nodoushan

Sima Yadegari

Sharareh Moghim

Bahram Nasr Isfahani

Hossein Fazeli

Farkhondeh Poursina

Pourya Nasirmoghadas

Hajieh Ghasemian Safaei

Affiliations

Soon will be listed here.

Abstract

Background: is an opportunistic and Gram-negative pathogen that is used as the most important factor in burn wound infections, and due to the rapid acquisition of multidrug resistance (MDR), it causes high mortality rates in these sectors. Thus, diagnosis and assessment of antibiotic resistance patterns are very important in these patients. The aim of this study was to evaluate antibiotic resistance pattern and determining MDR.

Materials And Methods: In this study, phenotypic, biochemical, and polymerase chain reaction tests were used to identify from 120 wound burn samples that 96 samples were detected to species. In the next step, according to the Clinical and Laboratory Standard Institute standard guidelines, antibiogram test was performed by disk diffusion method for amikacin, ciprofloxacin, norfloxacin, gentamicin, cefepime, aztreonam, meropenem, colistin, ceftazidime, and piperacillin-tazobactam antibiotics. Antibiotic data were analyzed by WHONET software; finally, the rate of antibiotic resistance and MDR strains was determined.

Results: The highest antibiotic resistance belonged to amikacin (94.8%) and norfloxacin (90.6%); in contrast, colistin (8.3%) had the lowest and the MDR strains were MDR (95.8%) and extensively drug resistance (XDR) (87.5%).

Conclusion: In this study, there was MDR with an alarming rate including MDR (95.8%), XDR (87.5%), and pan-drug resistance (0%). As a result, given antibiotics to patients should be controlled by the antibiogram results to avoid increasing MDR strains.

Citing Articles

Survey of probable synergism between melittin and ciprofloxacin, rifampicin, and chloramphenicol against multidrug-resistant .

Sedaghati M, Akbari R, Lotfollahi Hagghi L, Yousefi S, Mesbahi T, Delfi M Front Microbiol. 2024; 15:1480299.

PMID: 39640853 PMC: 11617520. DOI: 10.3389/fmicb.2024.1480299.

Prevalence of colistin resistance in clinical isolates of : a systematic review and meta-analysis.

Narimisa N, Keshtkar A, Dadgar-Zankbar L, Bostanghadiri N, Far Y, Shahroodian S Front Microbiol. 2024; 15:1477836.

PMID: 39473844 PMC: 11520190. DOI: 10.3389/fmicb.2024.1477836.

Antimicrobial blue light inactivation of Pseudomonas aeruginosa: Unraveling the multifaceted impact of wavelength, growth stage, and medium composition.

Wang Y, Li X, Chen H, Yang X, Guo L, Ju R J Photochem Photobiol B. 2024; 259:113023.

PMID: 39241393 PMC: 11390306. DOI: 10.1016/j.jphotobiol.2024.113023.

Extensively drug-resistant : clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal - A cross-sectional and retrospective observational study.

Mendes Pedro D, Paulo S, Mimoso Santos C, Fonseca A, Cristino J, Pereira A Front Microbiol. 2024; 15:1347521.

PMID: 38414772 PMC: 10896734. DOI: 10.3389/fmicb.2024.1347521.

Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance isolated from the clinical specimen.

Qader G, Jarjees K, Jarjees R J Med Life. 2022; 15(9):1105-1109.

PMID: 36415531 PMC: 9635232. DOI: 10.25122/jml-2021-0196.

References

Douglas M, Mulholland K, Denyer V, Gottlieb T . Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study. Burns. 2001; 27(2):131-5. DOI: 10.1016/s0305-4179(00)00084-x. View

Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M . Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Acta Med Iran. 2011; 49(10):675-9. View

Lari A, Alaghehbandan R, Nikui R . Epidemiological study of 3341 burns patients during three years in Tehran, Iran. Burns. 2000; 26(1):49-53. DOI: 10.1016/s0305-4179(99)00102-3. View

Vaez H, Faghri J, Nasr Isfahani B, Moghim S, Yadegari S, Fazeli H . Efflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals. Adv Biomed Res. 2014; 3:117. PMC: 4063115. DOI: 10.4103/2277-9175.133183. View

Strateva T, Ouzounova-Raykova V, Markova B, Todorova A, Marteva-Proevska Y, Mitov I . Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J Med Microbiol. 2007; 56(Pt 7):956-963. DOI: 10.1099/jmm.0.46986-0. View

Van Bambeke F, Balzi E, Tulkens P . Antibiotic efflux pumps. Biochem Pharmacol. 2000; 60(4):457-70. DOI: 10.1016/s0006-2952(00)00291-4. View

Biswal I, Arora B, Kasana D, Neetushree . Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution. J Clin Diagn Res. 2014; 8(5):DC26-9. PMC: 4080000. DOI: 10.7860/JCDR/2014/7483.4383. View

Ozumba U, Jiburum B . Bacteriology of burn wounds in Enugu, Nigeria. Burns. 2000; 26(2):178-80. DOI: 10.1016/s0305-4179(99)00075-3. View

Moghoofei M, Fazeli H, Poursina F, Esfahani B, Moghim S, Vaez H . Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa. Jundishapur J Microbiol. 2016; 8(11):e25250. PMC: 4735832. DOI: 10.5812/jjm.25250. View

10.

Morales E, Cots F, Sala M, Comas M, Belvis F, Riu M . Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Serv Res. 2012; 12:122. PMC: 3412693. DOI: 10.1186/1472-6963-12-122. View

11.

Gad G, El-Domany R, Zaki S, Ashour H . Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007; 60(5):1010-7. DOI: 10.1093/jac/dkm348. View

12.

Stover C, Pham X, Erwin A, Mizoguchi S, Warrener P, Hickey M . Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000; 406(6799):959-64. DOI: 10.1038/35023079. View

13.

Mirsalehian A, Feizabadi M, Nakhjavani F, Jabalameli F, Goli H, Kalantari N . Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2009; 36(1):70-4. DOI: 10.1016/j.burns.2009.01.015. View

14.

Sauer K, Camper A, Ehrlich G, Costerton J, Davies D . Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002; 184(4):1140-54. PMC: 134825. DOI: 10.1128/jb.184.4.1140-1154.2002. View

15.

Altoparlak U, Aktas F, Celebi D, Ozkurt Z, Akcay M . Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns. 2005; 31(6):707-10. DOI: 10.1016/j.burns.2005.02.017. View

16.

Nadal Jimenez P, Koch G, Thompson J, Xavier K, Cool R, Quax W . The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 2012; 76(1):46-65. PMC: 3294424. DOI: 10.1128/MMBR.05007-11. View

17.

Kaushik R, Kumar S, Sharma R, Lal P . Bacteriology of burn wounds--the first three years in a new burn unit at the Medical College Chandigarh. Burns. 2001; 27(6):595-7. DOI: 10.1016/s0305-4179(01)00023-7. View

18.

Agnihotri N, Gupta V, Joshi R . Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study. Burns. 2004; 30(3):241-3. DOI: 10.1016/j.burns.2003.11.010. View

19.

Pena C, Gomez-Zorrilla S, Oriol I, Tubau F, Dominguez M, Pujol M . Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis. 2013; 32(3):413-20. DOI: 10.1007/s10096-012-1758-8. View

20.

Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V . Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J Trop Med Public Health. 2006; 36(6):1503-9. View